The global market for digital breast tomosynthesis (DBT) equipment is forecasted to attain USD 3,267.6 million by 2025, expanding at 8.9% CAGR to USD 7,664.8 million by 2035. In 2024, the revenue of digital breast tomosynthesis (DBT) equipment was around USD 2,884.0 million.
The growth of the digital breast tomosynthesis (DBT) equipment market is very much inclined with the prevalence of breast cancer and increasing requirement of diagnosis and screening of the breast cancer, which is constantly rising. Digital breast tomosynthesis or 3D breast tomosynthesis is a novel technology that enables the radiologists to diagnose the breast cancer in the most optimal manner.
This technique utilizes a series of 2-D images to obtain a 3-D image of the women’s breasts with computer reconstruction. The adoption rate of this equipment is quite high because of the rate of accuracy it provides while diagnosing breast cancer in women with dense breasts. When it comes to digital breast tomosynthesis, the possibility of providing false results is much less than that of the conventional mammography technique, which produces 2-D digital images of the breast.
As per the findings from the World Cancer Research Fund International, the cancer that is very common in women is breast cancer, and it has also been regarded as the most common cancer. Since the incidence is quite high, therefore, in order to increase the quality of patient care, it is important to perform the diagnosis and screening efficiently. This is quite advantageous for the growth of the digital breast tomosynthesis (DBT) equipment market.
-Equipment-Market.jpg "Digital Breast Tomosynthesis (DBT) Equipment Market")
In recent years, early detection of breast cancer has been really important for better prognosis and treatment of breast cancer. Various government, public, private, advocacy, and community group breast cancer education and awareness initiatives are ongoing at national, regional, or local levels. Early diagnosis and detection programs are an integral part of these initiatives.
For instance, the National Breast Cancer Foundation celebrates October as Breast Cancer Awareness Month so that awareness about the severity of breast cancer can be improved. This would positively impact the growth of the digital breast tomosynthesis (DBT) equipment market.
Other than this, technological advancements can be considered a recognizable driver for this market. DBT reduces around 15% the chances that women will need to revisit for additional breast imaging, thereby reducing both costs, psychological distress, time, and discomfort caused by a false negative recall. It offers increased specificity and sensitivity by reducing false positive recalls, leading to better cancer detection.
The detection of breast cancer has significantly improved when it comes to the combination of 2-D and 3-D mammography because this enables the mammary glands to appear in thin slices, which further enables the detection of hidden cancers in the breast.
Explore FMI!
Book a free demo
North America is the dominant region in the DBT equipment market because of its strong healthcare infrastructure, high levels of breast cancer screening awareness, and presence of top imaging technology companies.
The USA, in particular, drives this expansion with favorable reimbursement policies, an AI-powered imaging solutions explosion, and increased funding for breast cancer research. The FDA's continued approval of cutting-edge DBT systems drives the market forward.
Nevertheless, the expense of DBT machinery and upkeep is still a challenge, particularly in rural regions where access to cutting-edge imaging continues to be an issue. The area is also experiencing a pick-up from increasing adoption of AI-based diagnostic software, the implementation of mobile screening vehicles, and government-supported breast cancer screening schemes.
In addition, partnerships between imaging firms and healthcare facilities are increasing, promoting innovation and enhancing diagnostic capacity, ultimately making breast cancer screening more available and precise.
Europe is the most significant region for the DBT equipment market due to high-level government initiatives towards early detection of breast cancer, increased application of AI-aided imaging, and innovations that enable reduced radiation doses. Germany, France, and the UK are the pioneers, aided by robust healthcare policies and considerable investment in digital health technologies.
However, tough EMA regulations and the cost-containment strategies of public healthcare systems do not make it easy for emerging DBT technologies to gain traction in the market. Nevertheless, there is much momentum.
Additional nations are attempting to add DBT to national breast cancer screening programs, and collaborations between medical imaging firms and research institutions are pushing innovation ahead.
The growth of teleradiology services also makes DBT technology more accessible to underserved regions, enhancing access to improved diagnostics devices. And the region's move toward value-based healthcare is driving more extensive adoption of DBT as part of integrated breast cancer care.
Asia-Pacific is rapidly advancing as an emerging market with tremendous growth potential for DBT equipment due to escalating breast cancer cases, a huge overhaul of healthcare infrastructure, and growing investment in cutting-edge medical imaging technology.
The key markets, namely China, Japan, and India, fueling growth are mainly supported by huge government efforts to expand breast cancer screening programs and enhance access to next-generation imaging solutions.
The market, however, also confronts other significant challenges. Substantial initial expenditures for DBT systems, insufficient numbers of trained radiologists, and varying levels of access to healthcare along urban-rural interfaces would ultimately restrain massive market penetration.
Nonetheless, increased implementation of artificial intelligence-based diagnostic solutions and widening private-owned healthcare sector systems are increasingly bridging the gap and ensuring market expansion.
Government and NGO-initiated breast cancer screening campaigns are playing an important role in boosting screening, while tactical partnerships between international imaging companies and regional healthcare systems are facilitating the installation of DBT systems in the region.
Furthermore, ramping up efforts to integrate DBT into national cancer screening programs will also continue to support market growth, thus positioning this segment as a pioneer in Asia-Pacific for DBT adoption.
Training Requirements and Workflow Challenges Restrain Market Growth
Implementation issues can be considered a restraining factor for the growth of the digital breast tomosynthesis (DBT) equipment market. Per the Mammography Quality Standards Act, the new modality training requirement for DBT includes 8 hours of training obtained on any DBT system or general DBT training.
It means that the dedicated professionals in the USA are required to complete eight hours of dedicated tomosynthesis training.
DBT image sets reading requires almost double the time required for interpretation of 2-D mammograms due to the bulk of images produced, that is, approx. 200 images compared to four for a 2-D view. Radiologists will need to learn to read master images.
Rising Adoption of 3-D Mammography Presents Growth Opportunities
The DBT imaging equipment market is poised for significant growth, courtesy of the increased uptake of 3-D mammography, which is superior to the old 2-D technology. In clinical trials after clinical trials, 3-D mammography has been shown to detect cancer more effectively, particularly invasive cancer, and thus, more healthcare practitioners are switching over.
This better precision ensures that fewer patients will have to take unnecessary biopsies, reducing expenses and rendering the whole process less traumatic for patients. These clear-cut advantages should increase demand for DBT machines, setting new possibilities for market expansion.
Advances in AI-Aided Imaging: AI-powered image analysis software is enhancing the accuracy of DBT scans, eliminating false positives, and aiding radiologists in early tumor detection, making the diagnosis more confident and efficient. AI-powered decision support tools are also being incorporated into DBT systems, enabling radiologists to prioritize high-risk cases more efficiently.
Regulatory and Policy Initiatives: Governments and health authorities are adopting policies to include DBT within national breast cancer screening programs through enhanced reimbursement coverage and standardized screening guidelines. Regulatory bodies are also pushing research on dose-optimized DBT solutions for weighing safety and efficacy.
Integration of AI-Powered Breast Imaging Solutions: AI application in DBT systems increases automation, maximizing image interpretation, and minimizing radiologist workload, resulting in quicker and more precise breast cancer diagnoses. AI-powered triage systems also optimize workflow efficiency by highlighting suspicious findings for radiologist evaluation.
Development of Ultra-Low-Dose and Portable DBT Systems: Continued research on minimizing radiation exposure with high image quality fuels the creation of safer DBT technologies to facilitate wider adoption in various healthcare environments. The development of small and mobile DBT units is also increasing access to breast imaging in outpatient clinics and community health centers.
The market for Digital Breast Tomosynthesis (DBT) machines has grown consistently with the improvement in imaging technologies, rising awareness about early detection of breast cancer, and the growing rate of breast cancer globally. Increasing attention toward individualized treatment and premature screening for cancer continued to push DBT for general adoption by standard mammography practices.
While the medical fraternity has rapidly experienced technology improvements, combining machine learning with AI for implementing them in DBT platforms intensified at this juncture as image analysis benefited from such incorporations, boosting diagnosis accuracy and decreasing reader time for radiologists.
Medical imaging facilities embraced cutting-edge DBT systems with automated workflows, reduced radiation doses, and improved imaging software to address the growing need for high-throughput and efficient screening.
Government campaigns for raising awareness about breast cancer and breast cancer screening programs in developed and emerging economies also accelerated the growth of the DBT market, creating new avenues for equipment suppliers and service providers.
Sustainability and patient safety became focal points, motivating the creation of energy-efficient technologies, eco-friendly components, and innovative shielding techniques to reduce radiation exposure.
To remain competitive and meet changing market demands, companies spent substantial research and development, traversed challenging regulatory processes, and established strategic alliances to strengthen their global positions and products, ultimately facilitating the expanding demand for quality DBT systems in breast cancer screening tests and diagnostics.
| Category | 2020 to 2024 Trends |
|---|---|
| Regulatory Landscape | Focus on the safety and effectiveness of DBT devices, with regulatory authorities allowing approvals of high-end imaging machines. |
| Technological Advancements | The usage of 2D/3D combination technology increases diagnostic sensitivity and workflow for the detection of breast cancer. |
| Consumer Demand | Greater awareness for more demand of early and accurate detection of breast cancer, using non-invasive and effective diagnosis equipment. |
| Market Growth Drivers | Increasing prevalence of breast cancer, technological advancements in imaging, and expansion in the healthcare sector of developed economies. |
| Sustainability | Leading endeavors in green manufacturing and reducing the carbon footprint of medical devices. |
| Supply Chain Dynamics | Relyence on tested-trusted distribution networks, with product availability in hospital and diagnostics channels being a principal concern. |
| Category | 2025 to 2035 Projections |
|---|---|
| Regulatory Landscape | Deployment of extensive guidelines for AI-aided DBT systems to guarantee uniform protocols and data security features. |
| Technological Advancements | Adoption of machine learning and AI algorithms to enhance image interpretation, create transportable DBT devices, and evolve 3D imaging technologies. |
| Consumer Demand | Increased desire for customized and accurate diagnostic products, with patients looking for state-of-the-art imaging technology that provides clear information about breast health and enables individualized treatment programs. |
| Market Growth Drivers | Penetration in emerging economies with enhanced healthcare infrastructure, rising investments in research and development of advanced imaging technologies, and strategic partnerships among medical device companies and healthcare providers. |
| Sustainability | Total embracing of sustainable processes such as deploying recyclable materials, environmentally friendly manufacturing operations, and electronic waste reduction practices linked to medical devices. |
| Supply Chain Dynamics | Optimization of supply chains using digital technology, increasing transparency and efficiency, and timely delivery of devices into varied healthcare facilities, including far-flung and underserved areas. |
Market Outlook
Rising chronic diseases such as breast cancer, the leading cancer in women in the United States, have created a greater demand for sophisticated diagnostic systems DBT. Other advanced imaging technologies have been embraced by healthcare professionals throughout the USA, as they also enable imaging of higher quality than traditional 2-D mammography but are primarily aimed at early detection and precise diagnosis.
The American medical device industry is competitive and has several manufacturers and suppliers specializing in DBT equipment, software, and accessories. Awareness creation campaigns, government screening programs, and increased healthcare spending have consistently propelled the demand for the incorporation of credible, non-invasive imaging methods in the detection of improved breast cancer cases, thereby enhancing better patient outcomes.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 7.5% |
Market Outlook
Germany's advanced healthcare system, combined with its high priority on preventive care and awareness of breast cancer screening, strongly drives the DBT market in Germany. Furthermore, the country has introduced DBT technology into established breast cancer screening programs based on increased accuracy and reduced false positive results over present mammography.
German healthcare providers prefer high accuracy and precision, driving the demand for cutting-edge DBT systems with AI integration to fine-tune the diagnostic workflow. The stringent regulation on standards and advantageous reimbursement policies further encourage hospitals and diagnostic centers to invest in DBT machines, positioning Germany as an unrivaled leader in medical imaging across Europe.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Germany | 6.0% |
Market Outlook
The growing Chinese DBT market is driven by the country's strengthening health infrastructure and rising government contributions to advanced medical technologies. In conjunction with increasing public awareness for early detection, these factors are majorly boosting DBT system demand in China owing to rising incidences of breast cancer.
The Chinese elderly population further adds to the burden of diagnosis, necessitating accurate and effective screening methods. Manufacturers in this country are growing proactive in the market by providing low-cost DBT solutions, particularly required by urban and rural facilities. It is mainstream government endeavours such as breast cancer screening programs and health reforms that endorse the introduction of DBT technology across the country.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| China | 9.2% |
Market Outlook
The Indian Digital Breast Tomosynthesis market has been envisioned to grow owing to the high incidence of breast cancer and rising awareness on the urgent need for early diagnosis. However, high-tech healthcare access is a major challenge in the rural regions of India.
The private sector is booming, while there are several steps taken towards the betterment of healthcare access through government-led health initiatives, such as Ayushman Bharat. In the process, more women in urban and semi-urban regions have better access to breast cancer screening, thus propelling DBT adoption.
Nevertheless, cost remains a key driver for India; there is a high demand for reasonably priced and portable DBT systems. The private diagnostic centers, in collaboration with government health programs, are set to widen the reach of DBT technology to a larger segment of the population.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| India | 8.6% |
Market Outlook
The Brazilian market for DBT is being driven by increasing promotional efforts for screening programs related to breast cancer by various public health programs. The government of Brazil is contributing its share to make the initiation of this venture by becoming more and more proactive in generating awareness through nationwide campaigns for early detection, like "Outubro Rosa" or "Pink October," which in turn has increased awareness and fueled demand for cutting-edge mammography solutions like DBT.
Private health is involved in such evolution, with large-level urban locations demanding this new technology and driving it through an increasing tide of specialist diagnostic centers for quick implementation in the wake of anticipated economic downturns.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Brazil | 4.6% |
3-D DBT Equipment Leads Market Growth with Technological Advancements and Global Adoption
3-D digital breast tomosynthesis (DBT) products are the highest-growing segment available in the industry, providing higher imaging quality over conventional 2D mammography. It features greater accuracy in detecting breast cancer, fewer false positives, and lower recall rates, and as such, has become the primary choice for the detection and diagnosis of breast cancer.
The growth is fueled by escalating cases of breast cancer, growth in government-initiated screening activities, and rapid adoption of technologically advanced image technologies. North America and Europe lead in 3-D DBT adoption with established healthcare infrastructure and robust regulatory backing, whereas Asia-Pacific is experiencing fast growth with increasing breast cancer awareness initiatives and enhanced access to healthcare.
Emerging trends involve AI-based DBT systems for computer-aided lesion detection, handheld DBT solutions for decentralized screening, and the integration of DBT with molecular imaging for enhanced diagnostic accuracy.
Rising Demand for Cost-Effective 3-D Upgradation Solutions Fuels Market Expansion
Healthcare centers are increasingly turning to 3-D upgrade to improve their current 2D mammography systems without incurring the expense of new DBT technology. The upgrades allow conventional mammography units to take 3D images, enhancing the diagnostic capability and maintaining investment.
The increased demand for low-cost breast cancer screening solutions, growing deployment of hybrid imaging technologies, and government initiatives to push breast cancer diagnostics are propelling market growth.
North America and Europe are presently the leaders in 3-D upgradation adoption, followed by increasing interest from Asia-Pacific and Latin America driven by cost-saving healthcare investments. Emerging innovations will probably place emphasis on cloud-based 3-D upgradation software, artificial intelligence workflow optimization for increased efficiency, and advanced image reconstruction algorithms for improved clarity in dense breast tissue.
Hospitals Lead DBT Adoption with Advanced Imaging Integration and Enhanced Patient Care
Hospitals are the largest end-user segment in the DBT equipment market since they are the initial contact points for breast cancer diagnosis and treatment. Large cancer centers and hospitals opt for high-end DBT systems, AI-based diagnostic software, and PACS (Picture Archiving and Communication Systems) for streamlined workflow and better patient outcomes.
Growing incidence of breast cancer, growing government expenditure on hospital-based cancer screening programs, and expanding use of DBT in multi-specialty hospitals are driving demand. North America and Europe are leaders in hospital-based DBT adoption, while the Asia-Pacific region is seeing growth driven by increasing hospital infrastructure and rising public-private healthcare collaborations.
Near-term trends involve robot-assisted DBT imaging for accurate diagnosis, AI-based radiology decision support systems, and next-generation DBT machines with smaller doses of radiation exposure for enhanced safety in screening.
Diagnostic Centers Drive Market Growth with Decentralized Screening and AI-Enhanced Solutions
Diagnostic centers are becoming primary adopters of DBT technology as the number of patients opting for outpatient imaging continues to grow and the trend towards decentralized breast cancer screening programs gains speed. Diagnostic centers offer high-throughput breast imaging, which enhances patient access to early cancer detection and minimizes wait times.
Demand for specialty imaging procedures, growing collaborative arrangements between oncology clinics and diagnostic centers, and increasing investment in AI-enhanced DBT imaging solutions are driving market expansion. North America and Europe have led to DBT adoption on a diagnostic center basis, and Asia-Pacific and Latin America are witnessing increasing demand as standalone diagnostic chains grow.
Future developments are likely to incorporate cloud-integrated DBT platforms for remote consultations in radiology, AI-powered automated DBT reporting, and miniaturized DBT systems optimized for ambulatory diagnostic centers.
To strengthen their presence around the globe and improve their business strategies, the key players are involved in various expansions, collaborations, and mergers and acquisitions. These are the top three key promotional strategies adopted by the key players in the digital breast tomosynthesis (DBT) equipment market.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Hologic, Inc. | 23.5% |
| GE Healthcare | 19.1% |
| Siemens Healthineers | 13.4% |
| Fujifilm Holdings Corp. | 9.2% |
| Canon Medical Systems | 4.5% |
| Other Companies (combined) | 30.1% |
| Company Name | Key Offerings/Activities |
|---|---|
| Hologic, Inc. | Market leader offering Selenia Dimensions and 3D Mammography solutions with AI-enhanced imaging. |
| GE Healthcare | Develop advanced DBT systems, including Senographe Pristina, focusing on patient comfort and high image clarity. |
| Siemens Healthineers | Specializes in 3D breast imaging solutions, including Mammomat Inspiration with automated workflow integration. |
| Fujifilm Holdings Corp. | Provides Aspire Cristalle, an innovative DBT system featuring advanced detector technology for high-resolution imaging. |
| Canon Medical Systems | Offers cutting-edge digital mammography and DBT systems with integrated artificial intelligence. |
Key Company Insights
Hologic, Inc. (23.5%)
A dominant player in the DBT market, Hologic leads with AI-powered 3D mammography and a strong focus on early breast cancer detection.
GE Healthcare (19.1%)
A leader in diagnostic imaging, GE Healthcare’s Senographe Pristina system emphasizes patient-centered design and high-resolution imaging.
Siemens Healthineers (13.4%)
A key innovator in breast imaging, Siemens integrates automated workflow and AI-driven enhancements in its DBT systems.
Fujifilm Holdings Corp. (9.2%)
Known for its high-performance imaging detectors, Fujifilm’s Aspire Cristalle DBT system enhances image quality while reducing radiation exposure.
Canon Medical Systems (4.5%)
A growing competitor in medical imaging, Canon focuses on AI-driven diagnostic solutions for breast cancer detection.
Beyond the leading companies, several other manufacturers contribute significantly to the market, enhancing product diversity and technological advancements. These include
The overall market size for digital breast tomosynthesis (DBT) equipment market was USD 3,267.6 million in 2025.
The digital breast tomosynthesis (DBT) equipment Market is expected to reach USD 7,664.8 million in 2035.
The increasing global prevalence of breast cancer is driving demand for advanced diagnostic tools like DBT to enable early and accurate detection.
The top key players that drives the development of digital breast tomosynthesis (DBT) equipment market are Hologic, Inc., GE Healthcare, Siemens Healthineers, Fujifilm Holdings Corp. and Canon Medical Systems
3-D equipment in product type of digital breast tomosynthesis (DBT) equipment market is expected to command significant share over the assessment period.
Epidemic Keratoconjunctivitis Treatment Market Overview – Growth, Trends & Forecast 2025 to 2035
Eosinophilia Therapeutics Market Insights – Trends & Forecast 2025 to 2035
Endometrial Ablation Market Analysis - Size, Share & Forecast 2025 to 2035
Endotracheal Tube Market - Growth & Demand Outlook 2025 to 2035
Encephalitis Treatment Market - Growth & Future Trends 2025 to 2035
Edward’s Syndrome Treatment Market – Growth & Future Prospects 2025 to 2035
Digital Breast Tomosynthesis (DBT) Equipment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
